Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects

Chronic Kidney Disease(CKD) Clinical Trial

Official title:
Open-Label Assessment of the Effects of Itraconazole and Rifampicin on HRS-1780 Pharmacokinetics in Healthy Subjects

Status Not yet recruiting

Clinical Trial Summary

The study was designed to evaluate the pharmacokinetic effects of itraconazole and rifampicin on HRS-1780 after oral administration of HRS-1780 tablets in healthy subjects

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06344936
Study type	Interventional
Source	Shandong Suncadia Medicine Co., Ltd.
Contact	Na Li
Phone	+86- 15618362889
Email	na.li@hengrui.com
Status	Not yet recruiting
Phase	Phase 1
Start date	April 2024
Completion date	July 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04579315` - Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease	N/A
Recruiting	`NCT05732727` - Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease	Phase 3
Active, not recruiting	`NCT02165878` - KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease
Active, not recruiting	`NCT04616612` - Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study	N/A
Completed	`NCT01227616` - Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis	Phase 4